Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 18;14(2):e240477.
doi: 10.1530/EC-24-0477. Print 2025 Feb 1.

Prevalence and management of hypertension in Turner syndrome: data from the International Turner Syndrome (I-TS) registry

Prevalence and management of hypertension in Turner syndrome: data from the International Turner Syndrome (I-TS) registry

Shani A D Mathara Diddhenipothage et al. Endocr Connect. .

Abstract

Introduction: Cardiovascular disease is the most common cause of death in Turner syndrome (TS) for which arterial hypertension has a direct influence and is a key modifiable risk factor.

Objective: To investigate the prevalence and patterns of hypertension diagnosis and management in adult patients with TS who are registered in a large international multicentre database (TS-HTN study).

Methods: Retrospective multicentre observational study of patients aged ≥18 years included in the I-TS (International-TS) registry (2020-2022), using registry and participating centre-collected data.

Results: Twelve international centres participated, including 182 patients with a median age of 28 years (IQR 23-37.2). Arterial hypertension was recorded in 13.2% (n = 24). The median age at hypertension diagnosis was 27 years (range 10-56), with 92% aged less than 50 years at diagnosis. The majority (75%) were classified as primary hypertension (n = 18). In binomial regression analysis, higher body mass index was the only parameter significantly associated with the occurrence of hypertension (B = 1.487, P = 0.004). Among patients with aortic disease (n = 9), 50% had systolic BP ≥ 130 mmHg and 66.6% had diastolic BP ≥ 80 mmHg during the last clinic review. Angiotensin-converting enzyme inhibitors were the most common (n = 16) medication prescribed, followed by angiotensin receptor blockers (n = 6), beta-blockers (n = 6) and calcium channel blockers (n = 6).

Conclusions: Arterial hypertension is common in TS and occurs at a young age. Overweight/obesity was a notable risk factor for hypertension. The frequency of suboptimal BP control among high-risk patients highlights the importance of increased awareness and TS-specific consensus guidance on management.

Keywords: International Turner Syndrome Registry; Turner syndrome; hypertension.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of this work.

Figures

Figure 1
Figure 1
Age distribution (at the inclusion in the study) of the cohort in relation to the hypertension diagnosis (n = 182).
Figure 2
Figure 2
Blood pressure control recorded at the most recent clinic visit among patients with and without aortic pathology. Blood pressure data were available for 92 individuals (50.5%) of the total cohort and 22 individuals (91.7%) with hypertension diagnosis. DBP:diastolic blood pressure; SBP: systolic blood pressure.

Similar articles

References

    1. Gravholt CH, Andersen NH, Conway GS, et al. . Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner syndrome meeting. Eur J Endocrinol 2017. 177 G1–G70. (10.1530/EJE-17-0430) - DOI - PubMed
    1. Schoemaker MJ, Swerdlow AJ, Higgins CD, et al. . Mortality in omen with Turner syndrome in Great Britain: national cohort study. J Clin Endocrinol Metab 2008. 93 4735–4742. (10.1210/jc.2008-1049) - DOI - PubMed
    1. Stochholm K, Juul S, Juel K, et al. . Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 2006. 91 3897–3902. (10.1210/jc.2006-0558) - DOI - PubMed
    1. Jones L, Blair J, Hawcutt DB, et al. . Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions. J Hypertens 2023. 41 203–211. (10.1097/HJH.0000000000003321) - DOI - PubMed
    1. Landin-Wilhelmsen K, Bryman I & Wilhelmsen L. Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab 2001. 86 4166–4170. (10.1210/jcem.86.9.7818) - DOI - PubMed

LinkOut - more resources